Thodou E, Kontogeorgos G, Horvath E, Kovacs K, Smyth H S, Ezzat S
Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada.
Arch Pathol Lab Med. 1995 Aug;119(8):748-50.
Recurrent pituitary tumors can sometimes pose a diagnostic and therapeutic challenge. We report a case of a 43-year-old man who presented twice, 13 years apart, with pituitary adenoma marked by headaches, visual impairment, and no signs of endocrinologic abnormality. At initial presentation computed tomographic scan documented a pituitary mass eroding the sellar floor, with suprasellar and parasellar extension. The patient underwent transsphenoidal surgery and the tumor was classified as a silent corticotroph adenoma, subtype 2. Thirteen years later, clinical symptoms of a destructive pituitary mass reappeared. This time, the adenoma revealed typical ultrastructural features of an oncocytoma; it had a different immunocytochemical profile from the first tumor. Given these striking morphologic differences, we consider the two adenomas to represent asynchronous, de novo formations. We conclude that the recurrence of a resected pituitary tumor may also represent a metachronous development of two distinct pituitary adenomas.
复发性垂体瘤有时会带来诊断和治疗上的挑战。我们报告一例43岁男性患者,该患者在相隔13年的时间里两次出现垂体腺瘤,表现为头痛、视力损害,且无内分泌异常迹象。初次就诊时,计算机断层扫描显示垂体肿块侵蚀蝶鞍底,向鞍上和鞍旁延伸。患者接受了经蝶窦手术,肿瘤被分类为2型无功能促肾上腺皮质激素腺瘤。13年后,破坏性垂体肿块的临床症状再次出现。这次,腺瘤显示出典型的嗜酸性细胞瘤超微结构特征;其免疫细胞化学特征与第一个肿瘤不同。鉴于这些显著的形态学差异,我们认为这两个腺瘤代表异步的、新生的形成。我们得出结论,切除的垂体瘤复发也可能代表两个不同垂体腺瘤的异时性发展。